Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2018, Article ID 3696914, 8 pages
https://doi.org/10.1155/2018/3696914
Review Article

How Hippo Signaling Pathway Modulates Cardiovascular Development and Diseases

1Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510100, China
2Guangzhou Medical University, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510000, China
3Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha 410013, China

Correspondence should be addressed to Mingyi Zhao; moc.qq@37736163

Received 19 October 2017; Accepted 12 November 2017; Published 8 February 2018

Academic Editor: Abdallah Elkhal

Copyright © 2018 Wenyi Zhou and Mingyi Zhao. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Li, X. Wang, J. M. Capasso, and A. M. Gerdes, “Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development,” Journal of Molecular and Cellular Cardiology, vol. 28, no. 8, pp. 1737–1746, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Mollova, K. Bersell, S. Walsh et al., “Cardiomyocyte proliferation contributes to heart growth in young humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 4, pp. 1446–1451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Meng, T. Moroishi, and K.-L. Guan, “Mechanisms of Hippo pathway regulation,” Genes & Development, vol. 30, no. 1, pp. 1–17, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. F.-X. Yu, B. Zhao, and K.-L. Guan, “Hippo pathway in organ size control, tissue homeostasis, and cancer,” Cell, vol. 163, no. 4, pp. 811–828, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Hergovich, “The roles of NDR protein kinases in Hippo signalling,” Genes, vol. 7, no. 5, p. 21, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Zhang, F. Tang, L. Terracciano et al., “NDR functions as a physiological YAP1 kinase in the intestinal epithelium,” Current Biology, vol. 25, no. 3, pp. 296–305, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. D. P. Del Re, “Hippo signaling in the heart – non-canonical pathways impact growth, survival and function,” Circulation Journal, vol. 80, no. 7, pp. 1504–1510, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Zhao, X. Wei, W. Li et al., “Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control,” Genes & Development, vol. 21, no. 21, pp. 2747–2761, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Gibault, M. Corvaisier, F. Bailly, G. Huet, P. Melnyk, and P. Cotelle, “Non-photoinduced biological properties of verteporfin,” Current Medicinal Chemistry, vol. 23, no. 11, pp. 1171–1184, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Zhao, L. Li, K. Tumaneng, C. Y. Wang, and K. L. Guan, “A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP,” Genes & Development, vol. 24, no. 1, pp. 72–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Moon, W. Kim, S. Kim et al., “Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization,” EMBO Reports, vol. 18, no. 1, pp. 61–71, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Guo, X. Zhang, and G. P. Pfeifer, “The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2,” The Journal of Biological Chemistry, vol. 286, no. 8, pp. 6253–6261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Matsuda, P. Zhai, S. Sciarretta et al., “NF2 activates Hippo signaling and promotes ischemia/reperfusion injury in the heart,” Circulation Research, vol. 119, no. 5, pp. 596–606, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Xin, Y. Kim, L. B. Sutherland et al., “Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size,” Science Signaling, vol. 4, no. 196, article ra70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Heallen, M. Zhang, J. Wang et al., “Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size,” Science, vol. 332, no. 6028, pp. 458–461, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Wang, G. Hu, F. Liu et al., “Deletion of yes-associated protein (YAP) specifically in cardiac and vascular smooth muscle cells reveals a crucial role for YAP in mouse cardiovascular development,” Circulation Research, vol. 114, no. 6, pp. 957–965, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Singh, S. Ramesh, D. M. Cibi et al., “Hippo signaling mediators Yap and Taz are required in the epicardium for coronary vasculature development,” Cell Reports, vol. 15, no. 7, pp. 1384–1393, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Lin and W. T. Pu, “Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation,” Stem Cell Research, vol. 13, Part B, no. 3, pp. 571–581, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. D. P. Del Re, T. Matsuda, P. Zhai et al., “Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice,” The Journal of Clinical Investigation, vol. 120, no. 10, pp. 3555–3567, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Zi, A. Maqsood, S. Prehar et al., “The mammalian Ste20-like kinase 2 (Mst2) modulates stress-induced cardiac hypertrophy,” The Journal of Biological Chemistry, vol. 289, no. 35, pp. 24275–24288, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Matsui, N. Nakano, D. Shao et al., “Lats2 is a negative regulator of myocyte size in the heart,” Circulation Research, vol. 103, no. 11, pp. 1309–1318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Fan, J. Song, Y. He et al., “The TIR/BB-loop mimetic AS-1 attenuates mechanical stress-induced cardiac fibroblast activation and paracrine secretion via modulation of large tumor suppressor kinase 1,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1862, no. 6, pp. 1191–1202, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. A. von Gise, Z. Lin, K. Schlegelmilch et al., “YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 7, pp. 2394–2399, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Lin, A. von Gise, P. Zhou et al., “Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model,” Circulation Research, vol. 115, no. 3, pp. 354–363, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. D. P. Del Re, Y. Yang, N. Nakano et al., “Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury,” The Journal of Biological Chemistry, vol. 288, no. 6, pp. 3977–3988, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Yang, D. P. Del Re, N. Nakano et al., “miR-206 mediates YAP-induced cardiac hypertrophy and survival,” Circulation Research, vol. 117, no. 10, pp. 891–904, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Kim, Y. H. Kim, J. Kim et al., “YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation,” The Journal of Clinical Investigation, vol. 127, no. 9, pp. 3441–3461, 2017. View at Publisher · View at Google Scholar
  28. H.-J. Choi, H. Zhang, H. Park et al., “Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2,” Nature Communications, vol. 6, p. 6943, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Marti, C. Stein, T. Blumer et al., “YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors,” Hepatology, vol. 62, no. 5, pp. 1497–1510, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Dai, P. She, F. Chi et al., “Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis,” The Journal of Biological Chemistry, vol. 288, no. 47, pp. 34041–34051, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Yuan, Y. Mao, W. Luo et al., “Palmitic acid dysregulates the Hippo–YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS–STING–IRF3 signaling mechanism,” The Journal of Biological Chemistry, vol. 292, no. 36, pp. 15002–15015, 2017. View at Publisher · View at Google Scholar
  32. M. Xin, Y. Kim, L. B. Sutherland et al., “Hippo pathway effector Yap promotes cardiac regeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 34, pp. 13839–13844, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Lin, P. Zhou, A. von Gise et al., “Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival,” Circulation Research, vol. 116, no. 1, pp. 35–45, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Tian, Y. Liu, T. Wang et al., “A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice,” Science Translational Medicine, vol. 7, no. 279, p. 279ra38, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Tao, P. C. Kahr, Y. Morikawa et al., “Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury,” Nature, vol. 534, no. 7605, pp. 119–123, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Ravikumar, S. Sarkar, J. E. Davies et al., “Regulation of mammalian autophagy in physiology and pathophysiology,” Physiological Reviews, vol. 90, no. 4, pp. 1383–1435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Mizushima and M. Komatsu, “Autophagy: renovation of cells and tissues,” Cell, vol. 147, no. 4, pp. 728–741, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. M. K. Choi, S. W. Ryter, and B. Levine, “Autophagy in human health and disease,” The New England Journal of Medicine, vol. 368, no. 7, pp. 651–662, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Boya, F. Reggiori, and P. Codogno, “Emerging regulation and functions of autophagy,” Nature Cell Biology, vol. 15, no. 8, p. 1017, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Taneike, O. Yamaguchi, A. Nakai et al., “Inhibition of autophagy in the heart induces age-related cardiomyopathy,” Autophagy, vol. 6, no. 5, pp. 600–606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. O. Pyo, S. M. Yoo, H. H. Ahn et al., “Overexpression of Atg5 in mice activates autophagy and extends lifespan,” Nature Communications, vol. 4, p. 2300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Maejima, S. Kyoi, P. Zhai et al., “Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2,” Nature Medicine, vol. 19, no. 11, pp. 1478–1488, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Wang, L. Zhang, J. Hu et al., “Mst1 participates in the atherosclerosis progression through macrophage autophagy inhibition and macrophage apoptosis enhancement,” Journal of Molecular and Cellular Cardiology, vol. 98, pp. 108–116, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Lin, L. Zhang, M. Zhang et al., “Mst1 inhibits CMECs autophagy and participates in the development of diabetic coronary microvascular dysfunction,” Scientific Reports, vol. 6, no. 1, article 34199, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Zhang, L. Zhang, J. Hu et al., “MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice,” Diabetologia, vol. 59, no. 11, pp. 2435–2447, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Hu, L. Zhang, Y. Yang et al., “Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1,” Journal of Pineal Research, vol. 62, no. 1, 2017. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Hu, L. Zhang, Z. Zhao et al., “OSM mitigates post-infarction cardiac remodeling and dysfunction by up-regulating autophagy through Mst1 suppression,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1863, no. 8, pp. 1951–1961, 2017. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Hu, W. Man, M. Shen et al., “Luteolin alleviates post-infarction cardiac dysfunction by up-regulating autophagy through Mst1 inhibition,” Journal of Cellular and Molecular Medicine, vol. 20, no. 1, pp. 147–156, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Zhang, J. Lin, S. Wang et al., “Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling,” Journal of Pineal Research, vol. 63, no. 2, 2017. View at Publisher · View at Google Scholar
  50. M. Zhang, Z. Zhao, M. Shen et al., “Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1863, no. 8, pp. 1962–1972, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. D. S. Wilkinson and M. Hansen, “LC3 is a novel substrate for the mammalian Hippo kinases, STK3/STK4,” Autophagy, vol. 11, no. 5, pp. 856-857, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Joffre, N. Dupont, L. Hoa et al., “The pro-apoptotic STK38 kinase is a new Beclin1 partner positively regulating autophagy,” Current Biology, vol. 25, no. 19, pp. 2479–2492, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. Q. Song, B. Mao, J. Cheng et al., “YAP enhances autophagic flux to promote breast cancer cell survival in response to nutrient deprivation,” PLoS One, vol. 10, no. 3, article e0120790, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Kanamori, G. Takemura, K. Goto et al., “The role of autophagy emerging in postinfarction cardiac remodelling,” Cardiovascular Research, vol. 91, no. 2, pp. 330–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. Z. Lin, H. Guo, Y. Cao et al., “Acetylation of VGLL4 regulates Hippo-YAP signaling and postnatal cardiac growth,” Developmental Cell, vol. 39, no. 4, pp. 466–479, 2016. View at Publisher · View at Google Scholar · View at Scopus